Free Trial
OTCMKTS:PPCB

Propanc Biopharma (PPCB) Stock Price, News & Analysis

Propanc Biopharma logo
$4.15 0.00 (0.00%)
As of 06/30/2025

About Propanc Biopharma Stock (OTCMKTS:PPCB)

Key Stats

Today's Range
$4.15
$4.15
50-Day Range
$1.99
$8.00
52-Week Range
$1.25
$145.46
Volume
3 shs
Average Volume
2,127 shs
Market Capitalization
$83 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PPCB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Propanc Biopharma and its competitors with MarketBeat's FREE daily newsletter.

PPCB Stock News Headlines

Propanc Biopharma Inc (PPCB)
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
VTXB Vortex Brands Co.
Propanc Biopharma, Inc. (PPCB)
See More Headlines

PPCB Stock Analysis - Frequently Asked Questions

Propanc Biopharma's stock was trading at $0.0002 at the beginning of the year. Since then, PPCB stock has increased by 2,074,900.0% and is now trading at $4.15.
View the best growth stocks for 2025 here
.

Propanc Biopharma Inc (OTCMKTS:PPCB) issued its earnings results on Thursday, May, 15th. The company reported ($12.50) EPS for the quarter.

Propanc Biopharma's stock reverse split on the morning of Tuesday, May 23rd 2023.The 1-1000 reverse split was announced on Tuesday, May 23rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

Shares of PPCB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Propanc Biopharma investors own include T2 Biosystems (TTOO), AppYea (APYP), Avis Budget Group (CAR), PayPal (PYPL), Synthetic Biologics (SYN), Corbus Pharmaceuticals (CRBP) and Delcath Systems (DCTH).

Company Calendar

Last Earnings
5/15/2025
Today
7/01/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:PPCB
Employees
1
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.82 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($493.34) per share
Price / Book
-0.01

Miscellaneous

Free Float
19,000
Market Cap
$83 thousand
Optionable
Not Optionable
Beta
2.24
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (OTCMKTS:PPCB) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners